Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05753449 · ClinicalTrials.gov registry record · NA
Burst-Type Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease
A NA study, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT05753449 is a NA study that was terminated before completion, run by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute). The registered enrollment target is 2 participants.
The verdict
NCT05753449, a NA study, was terminated before completion, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
This is a study to evaluate Deep brain stimulation (DBS) burst-type electrical stimulation programming verses standard DBS programming. Burst-type DBS is defined as a novel stimulation protocol in which intermittent bursts of traditional high-frequency rectangular wave stimulation are delivered. Burst type DBS may improve the efficacy and durability of DBS pulse generator.
Interventions
- DEVICE Baseline (or standard of care) DBS programming
- DEVICE Burst-type DBS electrical stimulation programming
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2022-08-24 |
| Est. Completion | 2024-02-21 |
| Phase | NA |
Sponsor
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)34 total trials
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05753449
The ClinicalTrials.gov registry entry for NCT05753449 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute), which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Baseline (or standard of care) DBS programming is the first listed.
NCT05753449 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05753449 about?
NCT05753449 is a clinical study titled "Burst-Type Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease". This is a study to evaluate Deep brain stimulation (DBS) burst-type electrical stimulation programming verses standard DBS programming. Burst-type DBS is defined as a novel stimulation protocol in which intermittent bursts of traditional high-frequency rectangular wave stimulation are delivered. Bur...
What is the current status of trial NCT05753449?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2022-08-24. Estimated completion is 2024-02-21.
What interventions are being tested in trial NCT05753449?
The interventions under investigation include: Baseline (or standard of care) DBS programming (DEVICE), Burst-type DBS electrical stimulation programming (DEVICE).
Who is sponsoring clinical trial NCT05753449?
This trial is sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute), which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.